These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24650305)

  • 21. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).
    Harding S; Khimdas S; Bonner A; Baron M; Pope J;
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S38-43. PubMed ID: 22691207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.
    Hoa S; Bernatsky S; Steele RJ; Baron M; Hudson M;
    Rheumatology (Oxford); 2020 May; 59(5):1108-1117. PubMed ID: 31535689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications.
    Fairley JL; Hansen D; Day J; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Stevens W; Ross L; Nikpour M
    Semin Arthritis Rheum; 2024 Apr; 65():152363. PubMed ID: 38316069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
    Maurer B; Graf N; Michel BA; Müller-Ladner U; Czirják L; Denton CP; Tyndall A; Metzig C; Lanius V; Khanna D; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1124-31. PubMed ID: 24981642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.
    Balbir-Gurman A; Yigla M; Guralnik L; Hardak E; Solomonov A; Rozin AP; Toledano K; Dagan A; Bishara R; Markovits D; Nahir MA; Braun-Moscovici Y
    Isr Med Assoc J; 2015 Mar; 17(3):150-6. PubMed ID: 25946765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
    Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
    J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frailty index to measure health status in people with systemic sclerosis.
    Rockwood MR; MacDonald E; Sutton E; Rockwood K; Baron M;
    J Rheumatol; 2014 Apr; 41(4):698-705. PubMed ID: 24584923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
    Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
    Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial lung disease in South Africans with systemic sclerosis.
    Ashmore P; Tikly M; Wong M; Ickinger C
    Rheumatol Int; 2018 Apr; 38(4):657-662. PubMed ID: 29185086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
    Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
    Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study.
    Wangkaew S; Intum J; Prasertwittayakij N; Euathrongchit J
    Clin Rheumatol; 2022 Oct; 41(10):3055-3063. PubMed ID: 35794291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
    De Luca G; Bosello SL; Berardi G; Rucco M; Canestrari G; Correra M; Mirone L; Forni F; Di Mario C; Danza FM; Pirronti T; Ferraccioli G
    Rheumatology (Oxford); 2015 Nov; 54(11):1991-9. PubMed ID: 26106211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.